Background
Seizures are identified as an ambulatory care sensitive (ACS) condition, where, in some cases, hospitalisation can be avoided with appropriate preventative care and management of the condition [1] [2] [3] . It is acknowledged that not all hospitalisations for seizures are preventable, including first seizures, febrile convulsions, seizures occurring from other diagnoses/non-epilepsy related causes, and uncontrolled epilepsy [4] , with up to 30-40% of recurring seizures resistant to current treatment options [5] . However, for others, patient education, counselling and seizuremanagement support targeting medication compliance and lifestyle management, have been suggested to reduce avoidable hospitalisations [6, 7] , with research indicating patients who achieve better management of their seizures and comorbidities are likely to significantly reduce their use of healthcare services [8] .
Other ACS conditions, including asthma and diabetes, have demonstrated the impact well-funded education and supports can play in reducing avoidable hospitalisations. Studies suggest rates of hospital admissions can be reduced by improving health selfefficacy and health literacy amongst patients and carers [9] [10] [11] [12] , whilst increasing the regularity of physician check-ups and producing patient action plans [12] [13] [14] [15] . In another study, children with asthma or epilepsy who were trained to identify signs of a pending asthma attack or seizure, and who were given strategies for managing their illness, had significantly fewer physician visits (asthma), and fewer hospital visits (epilepsy) over the course of a year compared to controls [16] .
As epilepsy presents very differently between children and adults, health care costs can also vary between the two age groups [17] . Paediatric epilepsy management is associated with higher numbers of hospital admissions and investigations, with subsequently higher direct costs [18] . In the United States, an estimated US$4.05bn was spent on potentially preventable paediatric hospital admissions in 2006, with asthma and epilepsy the first and fourth leading causes of hospitalisation [19] .
Accurate Australian prevalence rates for epilepsy, asthma and diabetes are limited; however self-report data from the Australian Bureau of Statistics (ABS) National Health Survey (NHS) in 2014-2015 indicate 10.8% of Australians had asthma, 5.1% diabetes, and 1.5% epilepsy and other episodic and paroxysmal disorders (ABS, 2015) [20] .
Although other studies have examined seizure-related hospital admission rates in Australia for the period 1998-2004 by demography including socio-economic status (SES) and indigenous vs. non-indigenous groups [21] , none have looked at children separately to adults and performed financial costings. This study determined: the rate and frequencies of first and subsequent hospital admissions coded for seizures, bronchitis/asthma, and diabetes in children and adults; the socio-demographic factors associated with admission and readmission; and the financial costs of hospitalisations.
Methods

Setting and data sources
De-identified hospital separation data from May 2012 to May 2014 were obtained from the Medical Records departments of five major South Australian public hospitals: the Women's and Children's Hospital; Flinders Medical Centre; Lyell McEwan Hospital; Queen Elizabeth Hospital; and the Royal Adelaide Hospital. These sites were selected as they are the major public paediatric or adult emergency hospital facilities in metropolitan South Australia.
South Australia has a population of just over 1,700,000, with estimates indicating this will increase to over 1.9 million by 2026 [22] . In 2014, 1,276,700 (75%) of South Australians lived in urban areas, with resident Aboriginal and Torres Strait Islander population estimated to be 39 773 [22] .
Hospital separation data were sent to the investigators as an excel file. The term 'separation' refers to the formal process where a hospital records the completion of an episode of treatment and/ or care for an admitted patient [23] . Data files included separations with selected AR-DRG codes presented in Table 1 . AR-DRGs are an Australian casemix classification system used to inform hospital funding allocations. Patients admitted to hospital are categorised into groups with analogous clinical conditions requiring similar hospital services [24] . The average cost per casemix-adjusted separation is a means of calculating the average cost of treating a range of different diagnoses after controlling for differences in complexity of care for an episode of care [25] . Additional information collected included: type of admission (inpatient or emergency); length of hospital stay (days); number of readmissions (determined by individual hospital patient ID numbers); care provided (surgical, medical); care type (acute, maintenance, other admitted patient care); and demographic data (age, gender, postcode, indigenous status, country of birth, ethnicity). The term 'separation' refers to the formal process where a hospital records the completion of an episode of treatment and/or care for an admitted patient [23] .
Data analysis
All analyses were conducted using SPSS (version 23). Descriptive statistics were used to compare number of hospitalizations for children and adults. We compared admissions by AR-DRG code and category (i.e. seizure, bronchitis/asthma, diabetes) as well as readmissions of patients in the dataset. Febrile convulsions are classified using a separate AR-DRG code, and were not included in the analysis. Differences between sociodemographic and socioeconomic variables for children and adults were also examined between the AR-DRG codes using Chi-Square and independent samples T-tests or Analysis of Variance (ANOVA) as appropriate. Socio-economic status was based on postcode Socio-Economic Index for Area (SEIFA), with lower decile values indicating higher disadvantage. This Index was developed by the Australian Bureau of Statistics and ranks areas in Australia according to relative advantage and disadvantage, based on the five yearly Census [26] and we also compared differences based on country of birth, indigenous status, age and gender. Differences in mean length of stay between AR-DRG codes were examined using Analysis of Covariance (ANCOVA) controlling for sociodemographic variables as co-variates.
Hospital costings
A macro-costing approach was used to estimate hospitalisation costs according to type and length of admission. Inpatient costs were estimated for each separation by multiplying the average cost per inpatient bed-day for each AR-DRG by the observed length of stay (days). The national average cost per inpatient bed-day for each AR-DRG was calculated by dividing the most recently reported average cost per AR-DRG by the average length of inpatient stay (see Table 1 ) [27, 28] . Finally, the total cost for each AR-DRG across the five major hospitals was estimated by summing the relevant separation costs. Emergency department (ED) costs were calculated by multiplying the national average cost for nonadmitted and admitted ED presentations by the total number of ED presentations [27] . Table 2 presents the rate and number of hospital separations between May 2012 and May 2014 for the three diagnosis groups for children and adults. The rate of total hospital separations for seizures was 649 per 100,000; lower than bronchitis/asthma (751/ 100,000), yet higher than diabetes (500/100,000).
Results
Admission trends
A high proportion of the total number of hospital separations were accounted for by subsequent separations. This was highest for children and adults with seizures, regardless of complexity. Forty-seven percent of paediatric separations for seizures +CSCC (B76A) were subsequent separations, as were 17% of separations for children with without ÀCSCC (B76B). A similar trend is noted for adults, with 25% subsequent separations among seizures +CSCC (B76A) (25%), compared with diabetes (22%) or asthma (14%). The number of total seizure-related separations for adults was higher than either asthma or diabetes across complexity.
It is noted the mean age of children admitted with seizures was 7 years. This was older than for asthma (5 years), and younger than diabetes (11 years), with more than half of admissions for seizures (50%) or asthma (63%) in children under the age of five years (F(2, 3037) = 391.2, p < 0.001). Significantly more males were admitted with asthma (66%) than seizures (58%) or diabetes (52%) (x 2 (2) = 38.0, p < 0.001). Children with seizures tended to live in postcodes with lower mean SEIFA decile scores at 5.0(4) than those with asthma or diabetes at both 5.0(5) (p = 0.052). There were no significant differences in first admissions between the three conditions by ethnicity, although the numbers of children born overseas were very low (93% of children with seizures were born in Australia; 95% asthma; 96% diabetes) (x 2 (2) = 4.1, p = 0.127). The proportion of children who identified as Indigenous Australian was highest amongst those admitted for seizures (4%; asthma 3%; diabetes 2%), however this failed to reach statistical significance between the three AR-DRG groups (x 2 (2) = 5.7, p = 0.057). Unlike first admissions, more children born outside of Australia were readmitted for seizures than expected by chance compared with children for asthma.
There were again significant differences in the socio-demographic characteristics of adults across all conditions at the first admission during the reference period. The mean age of adults admitted for seizures (51.3 years) was similar to those with asthma (51.0 years), yet younger than those admitted for diabetes (57.1 years) (F(2,4239) = 39.0, p = 0.001). This finding was consistent for both diabetes with and without catastrophic or severe complication/comorbidity. More men than women were admitted for seizures (52%) and diabetes (58%) without complication/comorbidity than expected by chance and fewer men were admitted for asthma (31%) (x 2 (2) = 227.6, p = 0.001). Socioeconomic status was on average low for all conditions, with mean SEIFA quintile scores for adults with seizures 4.0(4), and 3.0(4) for both asthma and diabetes. Adults with seizures without complications/comorbidity (B76B) were more likely to be Australian born (78%) compared with asthma (72%), or diabetes (71%) (x 2 (2) = 24.8, p = 0.001). Hospitalisations for Indigenous patients were lower than expected with 4% of patients presenting across all conditions. These socio-demographic patterns were largely reflected in differences between adults who were re-admitted to hospital during the reference period. Patients with subsequent separations for seizures or diabetes were older than those with asthma, and more women than men required re-admission.
Length of stay and hospitalisation costs in children
Across all separations, mean length of stay was shortest for seizures with an average of 1.49 days, with children with severe complication/comorbidity hospitalised for 5.09 days and children without complications for 1.31 days (Table 3 ). This was closely followed by bronchitis/asthma (1.54 days), with a mean 2.76 day stay with severe complication/comorbidity and 1.41 days without. The longest average hospital stay was for diabetes (2.77 days), with 3.55 days with severe complication/comorbidity and 2.76 days without. The clinical condition (seizures, bronchitis/asthma, diabetes) had a significant effect on the length of stay after controlling for socio-economic status, gender, age and country of birth, F (6, 4277) = 31.9, p = < 0.001. Significant differences on length of stay were noted between diabetes and seizures (p = < 0.001) and diabetes and bronchitis/asthma (p = < 0.001).
We compared length of stay and costs for the first and subsequent admissions separately (Table 3) . For the first admission during the study period, there was a significant effect for AR-DRG Group Code (seizures, bronchitis/asthma, diabetes) on length of stay controlling for socio-economic status, gender, age and country of birth, (F (6, 3031) = 35.6 p = < 0.001). Significant differences were demonstrated between diabetes and seizures (p = < 0.001) and diabetes and bronchitis/asthma (p = < 0.001).
There was no significant effect of AR-DRG Group Code on length of stay after controlling for socio-economic status, gender, age and country of birth for subsequent admission F (6, 630) = 1.9, p = 0.87 NS (SEIFA, Gender, Age & COB NS).
The mean cost per separation was highest for diabetes ($4438), followed by seizures ($2408) and asthma ($2084) ( Table 3 ).
Length of stay and hospitalisation costs in adults
Mean length of stay across all admissions was longest for diabetes (4.87 days), with patients with severe complication/ comorbidity staying an average of 8.14 days, compared with 3.5 days without complications (Table 3 ). This is closely followed by seizures (3.61 days), with a mean 7.11 day stay for seizures with severe complication/comorbidity and 2.14 days without. Asthma had the shortest hospital stays, with an average of 2.41 days (3.51 with E69A and 1.92 for E69B).
Among first admissions, there was a significant effect of DRG Group Code (Seizures, Bronchitis/Asthma, Diabetes) on length of stay after controlling for socio-economic status, gender, age and country of birth, F (2, 4218) = 36.636, p = <0.001. All contrasts were significant at p = <0.001. On subsequent admission, there was a significant effect of AR-DRG Group Code (seizures, bronchitis/ The mean cost per separation was again highest for diabetes ($7656), followed by seizures ($5691) and asthma ($3295).
Discussion
Main findings
Although epilepsy is less prevalent in the Australian population than other chronic conditions [20] , this study reports higher rates of seizure-related hospital separations than diabetes. In particular, a higher proportion of the total number of separations were subsequent hospitalisations among both children and adults with seizures than either asthma or diabetes.
This was most striking for paediatric seizures with catastrophic or severe complications/comorbidity, where almost half of all separations were subsequent admissions. This may reflect the unique and complex ongoing medical management required for children with recent diagnoses, childhood epilepsy syndromes, treatment-resistant cases, the need for complex diagnostic tests, and the challenges in establishing and maintaining pharmacological control [18] . Similarly for adults, the heterogeneity of seizure disorders and the complexity of its management, may contribute to increased rates of hospital readmissions, compared with asthma and diabetes.
In children, although length of stay was shortest, the average cost of seizure admissions was higher than asthma, at $2,408.17. Among adults, seizures incurred a higher average number of hospital bed days than asthma, with admissions carrying a greater average cost of $5,691.14.
Recent Australian data on the financial costs of hospital admissions for seizures are presented in the National Hospital Cost Data Collection Reports conducted by the Independent Hospital Pricing Authority (IHPA). Data from the Round 16 report from 2011 to 2012 [27] indicate that there were 4267 separations coded for B76A (seizures with complexity) and 21,149 separations for B76 B (seizures without complexity) across Australia. The average length of stay was 6.94 days and 1.99 days respectively, with an average cost of AU$9124 (B76A) and AU$3.271 (B76B). These figures closely mirror those presented in this South Australian study, which has been extended to separate admissions, length of stay, costs and sociodemographic details between children and adults, and provides comparison with two other chronic conditions (bronchitis/asthma and diabetes).
Admission rates among children in this study are consistent with data released by the Australian Institute of Health and Welfare [29] revealing paediatric hospitalisations for asthma were much higher than other chronic conditions (asthma, 324.4 per 100,000; epilepsy, 55.5 per 100,000; diabetes, 37.6 per 100,000). Similar to our findings, hospitalisations among boys were consistently higher than girls across all three conditions, with the frequency of hospitalisation higher among children under 5years of age admitted with epilepsy or asthma [29] . Our adult data also closely follow Australian trends, with national hospitalisation rates for diabetes (in particular type 2) by far the highest of the three chronic conditions, ranging from 234 per 100,000 (25-35 year olds), to 21,003 per 100,000 (75-84 year olds), with more males and lower socio-economic representation [30] . Adult asthma hospitalisation rates in major cities is considerably lower (83 per 100,000) [31] .
Amongst the South Australian population, Indigenous Australians comprise 1.7%, with 48% residing in major cities in this state [32] . Within the current metro study, Indigenous children represented 4% of seizure hospitalisations, 3% asthma hospitalisations and 2% diabetes hospitalisations. Indigenous adults represented 4% of admissions for seizures, asthma and diabetes each. Hospital admissions have been shown to be higher in indigenous patients across metro, regional and rural areas across all three conditions [21, 33, 34] . It is noted that in 2011-2012, estimates indicated only 88% of Indigenous patients were correctly identified in Australian public hospitals [35] , suggesting potentially higher than recorded numbers.
Paediatric and geriatric segments of the population place higher demands on hospitals, with differences across conditions and cohorts [36] . In particular, rural residential status, socio-economic disadvantage and male gender significantly increased the likelihood of hospitalisation for a chronic condition within adults [36] . Among children, we found significant differences between chronic conditions in gender (more males were admitted with asthma), and socioeconomic status (children admitted with seizures were from lower socio-economic postcodes). In adults, significant differences were noted between age (mean age of adults admitted with diabetes was older), gender (more males with seizures and diabetes without complications/comorbidity, and more females with asthma), socioeconomic status (adults admitted with diabetes were from lower socio-economic postcodes) and country of birth (adults with seizures without complications/comorbidity were more likely to be born in Australia), highlighting the importance of controlling for these factors when making comparisons across chronic conditions. A further implication is that preventive programs for the management of chronic illness need to be tailored to specific risk profiles that vary depending on age, gender, ethnicity, and area of residence.
Low socioeconomic trends resonate with international epilepsy research which report more frequent hospitalisations among both children and adults with epilepsy with lower socioeconomic status [37, 38] . Contributing factors are suggested to include perceptions of unmet health care needs [38] , and poor medication adherence, which are more prevalent among lower SES patients [39] , and closely associated with higher rates of hospitalisations [40, 41] . Interventions in clinical practice are needed to enhance persistence and adherence to antiepileptic drug treatment [40] . Suggested interventions include targeting healthcare systems to communicate effectively and enhance patient education [42] .
The financial burden associated with seizure hospitalisations as an ACSC support arguments for greater public funding of community programs, including hospital or community based Seizure Clinics, which may impact admission rates and reduce length of stay by improving health literacy, health self-efficacy and confidence. According to one UK study, a strong relationship exists between the quality of primary care in epilepsy management and the reduction of emergency visits [10] . In Singapore, high rates of potentially preventable provocating factors were implicated in nearly 80% of seizure admissions of patients with epilepsy, including self-reported non-compliance with anti-epileptic drugs and sleep deprivation [5] . Although a direct causal relationship was not established in their study, they highlight the role epilepsy education and lifestyle adjustment for seizure prevention can play in improving seizure control and reducing hospitalisations. Other research reiterates the importance of receiving appropriate epilepsy information from health care providers [43] , with an emphasis on the role epilepsy nurse educators and epilepsy social workers specialist nurse educators can play in providing comprehensive epilepsy education to enhance compliance [44] . In the US, a recent study has demonstrated a 28% reduction in seizure-related emergency department visits, and reduced unplanned paediatric hospitalizations by 43% following the introduction of a suite of interventions targeting improved access to an outpatient seizure clinic and increased epilepsy management education [6] . The most successful intervention identified was the seizure clinic, staffed by epilepsy nurse practitioners and social workers providing education, counselling and addressing psychosocial risk factors. In addition, revised seizure action plans and magnet reminders were developed to improve family caregiver's knowledge of medications, including emergency abortive medication.
Outcomes from significant investment in these measures can also be seen in asthma and diabetes. Substantial reductions in Australian asthma hospitalisation rates in both children (33%) and adults (45%) reported between 1998 and 99 and 2010-2011 have been suggested to be in-part the result of improvements in preventative management in the community [31] . Similarly, in diabetes, effective programs which lower potentially avoidable hospitalisations include specialist diabetes clinics [45] , and community-based diabetes management programs incorporating intensive education and management of risk factors [46, 47] .
Enhanced discharge and follow-up services to primary health care and community settings play an important role in lowering avoidable hospital readmissions [48] . These include early identification of patients who are at risk of hospitalisation, individually tailored patient education and confirming understanding of care plans, comprehensive discharge planning and coordination with other services, and scheduled follow-up. It is noted that interventions which target specific conditions are more effective in reducing potentially avoidable hospitalisations than broader policy approaches [49] , leading to significant savings and higher health care quality.
Limitations
A number of limitations in this study are acknowledged. The data analysed was from a 2 year period only; the dataset did not include information on patient admissions to a different hospital within the time period, which would lead to undercounting of readmissions; 'first admission' is the first admission during the 2 year time period, and may not be the patient's actual first admission to hospital; and hospital DRG coding inconsistencies may have been present (ie paediatric seizure admission coding may have favoured B76 B where B76A may have been more accurate) resulting in both our estimated costs and those performed by the IHPA potentially lower than is actually incurred.
Given the disparity in health outcomes between regional and metropolitan areas [50] , a separate investigation of urban and rural health care delivery for each jurisdiction is warranted. This study has provided data on metropolitan admission trends from five hospitals in South Australia, with examination and comparison with rural trends and other states and territories now required. Furthermore, the conditions investigated are associated with different population prevalences in the community.
Conclusions
This study has identified the rates of children and adults hospitalised for seizure related conditions across 5 major metropolitan hospitals in South Australia, and compared admission and readmission trends to bronchitis/asthma and diabetes. Each are identified as ambulatory care-sensitive conditions whereby hospitalisation is potentially preventable. Although epilepsy is less prevalent in the Australian population than other chronic conditions [17] , this study reports higher rates of seizurerelated hospital separations than diabetes, and more frequent readmissions. Following the lead of well-developed and resourced health promotion initiatives in asthma and diabetes, further investment in appropriate primary care, community education and seizure management services (including seizure clinics), need be targeted in an effort to reduce seizure related hospitalisations which may be avoidable through improved medication compliance and lifestyle, thereby minimising costs to the health budget and maximising health care quality.
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